Source:http://linkedlifedata.com/resource/pubmed/id/21499813
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2011-5-10
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1433-0563
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
603-4
|
pubmed:meshHeading |
pubmed-meshheading:21499813-Humans,
pubmed-meshheading:21499813-Male,
pubmed-meshheading:21499813-Mass Screening,
pubmed-meshheading:21499813-Proportional Hazards Models,
pubmed-meshheading:21499813-Prostate-Specific Antigen,
pubmed-meshheading:21499813-Prostatic Neoplasms,
pubmed-meshheading:21499813-Sweden
|
pubmed:year |
2011
|
pubmed:articleTitle |
[Old wine in new bottles? The study of Hugosson et al on PSA-based screening].
|
pubmed:affiliation |
Ärztlichen Zentrum für Qualität in der Medizin, Berlin, Deutschland.
|
pubmed:publicationType |
Journal Article
|